Table 1.

Patient characteristics

No. of patients110
Median age (y; range)64 (26–85)
Gender (male/female)71/39
Primary tumor site (n)
    Colon69
    Sigma-rectum junction11
    Rectum28
    Other *2
Previous chemotherapy (%)
    Irinotecan based95 (86.4)
    Fluoropyrimidine/capecitabine based93 (84.5)
    Oxaliplatin based84 (76.4)
No. of previous cancer treatments for advanced disease prior anti-EGFR moAbs (%)
    None13 (11.8)
    One15 (13.6)
    Two48 (43.6)
    Three28 (25.4)
    More than three6 (5.5)
Cutaneous toxicity (%)
    0–174 (67.3)
    2–332 (29.1)
    Unknown4 (3.6)
  • * Other: In one case, primary site was small bowel, and in one case, primary tumor sites were multiple (colon and rectum).